Categories: NewsPharmaceutical

Benchling Builds Digital Data Foundation Powering Sanofi AI-Driven R&D

Over 30 global teams and 1,500 scientists at Sanofi use Benchling for R&D data capture and analysis

SAN FRANCISCO, June 11, 2024 /PRNewswire/ — Benchling, the R&D Cloud powering the biotech industry, today announced that global pharmaceutical company Sanofi is using Benchling across more than 1,500 scientists from 30 teams. 

Benchling is working with Sanofi to transition from legacy R&D systems to a digital platform through Benchling R&D Cloud; this is an integral process to enable Sanofi’s AI-powered R&D ambition. As a result of Sanofi’s digital and AI leadership, R&D teams are able to scale and accelerate groundbreaking research processes in just hours instead of weeks.

“Sanofi is paving the way for a new era of biotechnology, where every stage of R&D is faster, smarter, and more automated,” said Sajith Wickramasekara, CEO and co-founder Benchling. “Sanofi’s adoption of Benchling unlocks their ability to harness AI. With our R&D Cloud, Sanofi scientists can do their best work and accelerate timelines for life-changing medicines.”

Benchling R&D Cloud is used by teams across Sanofi, including early discovery-omics such as precision oncology, core therapeutic pipeline teams including novel modalities like mRNA, all the way up the lifecycle to translational teams. Through Benchling’s R&D Cloud, complex data from various departments at Sanofi is aggregated, enabling better decision-making, analytics, and collaboration. This real-time visibility into standardized data across teams gives Sanofi high-quality inputs to gain new insight faster.

About Benchling
Benchling creates the software that powers the biotechnology industry, serving cutting-edge start-ups and more than half of the top 50 global biopharma companies. Over 200,000 scientists rely on the Benchling R&D Cloud as their central source of truth for scientific data, analysis, and collaboration. With software purpose-built for biology, Benchling is on a mission to unlock the power of biotechnology. To learn more, visit Benchling.com.

View original content:https://www.prnewswire.com/news-releases/benchling-builds-digital-data-foundation-powering-sanofi-ai-driven-rd-302168594.html

SOURCE Benchling

Staff

Recent Posts

Lions Celebrate a Successful Year of Service at the 106th Lions International Convention

OAK BROOK, Ill., June 25, 2024 /PRNewswire/ -- Lions International celebrated several milestones during the…

2 hours ago

INDUSTRY LEADER IN PATIENT CENTRICITY CALLS FOR ITS SYSTEM-WIDE ADOPTION IN NEW BOOK

Dr. Anthony Yanni publishes a wide-ranging case for patient-centered healthcare delivery and treatment development—a "long-overdue…

2 hours ago

CUNY SPH receives $5.2 million NIH grant renewal for cancer genomics research

NEW YORK, June 25, 2024 /PRNewswire/ -- The Informatics Technology for Cancer Research (ITCR) program…

2 hours ago

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

World's First AI to Detect 35 Cardiac Determinations, Including Heart Attack, Using a Reduced Leadset…

2 hours ago

WellSync makes available its virtual care service to Publix customers

New service enhances access to high-quality and affordable virtual care throughout the Southeast. TAMPA, Fla.,…

2 hours ago

FrontRunnerHC Joins athenahealth’s Marketplace Program to Unlock Efficiencies, Strengthen Financial Performance, and Improve the Patient Experience

Provides access to accurate patient insurance, demographic, and financial information for a better bottom line…

2 hours ago